Primary testicular lymphoma: the site matters.
Publication
, Journal Article
Stefanovic, A; Lossos, IS
Published in: Leuk Lymphoma
July 2010
Duke Scholars
Published In
Leuk Lymphoma
DOI
EISSN
1029-2403
Publication Date
July 2010
Volume
51
Issue
7
Start / End Page
1159 / 1160
Location
United States
Related Subject Headings
- Treatment Outcome
- Testicular Neoplasms
- Survival Rate
- Radiotherapy Dosage
- Male
- Lymphoma, Large B-Cell, Diffuse
- Immunology
- Humans
- Combined Modality Therapy
- Antineoplastic Combined Chemotherapy Protocols
Citation
APA
Chicago
ICMJE
MLA
NLM
Stefanovic, A., & Lossos, I. S. (2010). Primary testicular lymphoma: the site matters. Leuk Lymphoma, 51(7), 1159–1160. https://doi.org/10.3109/10428194.2010.481067
Stefanovic, Alexandra, and Izidore S. Lossos. “Primary testicular lymphoma: the site matters.” Leuk Lymphoma 51, no. 7 (July 2010): 1159–60. https://doi.org/10.3109/10428194.2010.481067.
Stefanovic A, Lossos IS. Primary testicular lymphoma: the site matters. Leuk Lymphoma. 2010 Jul;51(7):1159–60.
Stefanovic, Alexandra, and Izidore S. Lossos. “Primary testicular lymphoma: the site matters.” Leuk Lymphoma, vol. 51, no. 7, July 2010, pp. 1159–60. Pubmed, doi:10.3109/10428194.2010.481067.
Stefanovic A, Lossos IS. Primary testicular lymphoma: the site matters. Leuk Lymphoma. 2010 Jul;51(7):1159–1160.
Published In
Leuk Lymphoma
DOI
EISSN
1029-2403
Publication Date
July 2010
Volume
51
Issue
7
Start / End Page
1159 / 1160
Location
United States
Related Subject Headings
- Treatment Outcome
- Testicular Neoplasms
- Survival Rate
- Radiotherapy Dosage
- Male
- Lymphoma, Large B-Cell, Diffuse
- Immunology
- Humans
- Combined Modality Therapy
- Antineoplastic Combined Chemotherapy Protocols